More good news
All the travel is wearing on me, but I hope to fill in the details of my continued clear and positive response to ibrutinib in the trial at OSU sometime soon.
Labels: Clinical Trial NCT01217749, CT results, good news, ibrutinib
What started as a personal journey of a doctor turned patient morphed into a way to share what’s universal in dealing with cancer, in my case a nasty leukemia (CLL), a failed transplant and a successful clinical trial. The telling of my journey has become a journey to teach about CLL, related blood issues and all cancers. Please visit our new website http://cllsociety.org for the latest news and information. Smart patients get smart care™. If you want to reach me, email bkoffmanMD@gmail.com
Labels: Clinical Trial NCT01217749, CT results, good news, ibrutinib
2 Comments:
FYI: There will be two new trials shortly using ibrutinib as front line therapy. The under 70 patients will be treated at Mayo and the over 70 at Ohio State.
Thanks to folks like you, the expected positive results from these trials should help fast-track this drug. Be well, TomD
Brian, I've been following your posts ,they give me strength and hope , and often that best of medicines - a good chuckle . Looking forward to the next one and wishing you good luck with the trial .
Veronica
Post a Comment
Subscribe to Post Comments [Atom]
<< Home